C. David Allis (1951

Sharon Dent is professor of epigenetics and molecular carcinogenesis at the University of Texas MD Anderson Cancer Center in Houston.

You can also search for this author in PubMed Google Scholar

Shiv Grewal is NIH Distinguished Investigator and laboratory chief at the National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

You can also search for this author in PubMed Google Scholar

You have full access to this article via your institution.

Credit: Koji Sasahara/AP/Shutterstock

David (Dave) Allis was a pioneer in the biology of chromatin, the complex of protein and nucleic acid that makes up chromosomes. He revealed how modifications to it, specifically chemical changes to the histone proteins around which DNA wraps, affect gene expression and many other fundamental aspects of cellular function. His ‘histone code’ hypothesis suggested that other proteins read histone modifications, which are important for almost every process in eukaryotic cells that uses DNA as a template. Allis played a major part in elucidating how epigenetic changes — those beyond the genome — can affect human health and disease, suggesting entirely new avenues for therapy development. He has died aged 71.

Histone modifications were first reported by Vincent Allfrey in 1966, but before Allis's work, their significance and associated enzyme activities remained unclear. Allis showed that they had a direct link with the regulation of DNA's transcription into RNA and hence into expressed proteins. His work illuminated how the cell establishes and maintains patterns of gene expression, and laid the groundwork for understanding how a single genome can generate cells of many types. He received the Canada Gairdner International Award, the Breakthrough Prize in Life Sciences and the Albert Lasker Award for Basic Medical Research (with Michael Grunstein).

Allis was born in Cincinnati, Ohio, in 1951, and earned a PhD in biology from Indiana University Bloomington. During postdoctoral training with Martin Gorovsky at the University of Rochester, New York, he studied the freshwater protozoan Tetrahymena, a model organism that he carried into his independent research at Baylor College of Medicine in Houston, Texas. Allis set out to identify enzymes that add acetyl groups to histones (histone acetyltransferases, or HATs), reasoning that Tetrahymena, which has many acetylated histones, would be an excellent source of them. This decision demonstrated his knack for pursuing a unique line of inquiry with deliberation and commitment, which would prove pivotal in making significant advances.

His major breakthrough came in 1996, with his discovery of the enzyme GCN5, which acts to promote transcription, as a HAT (J. E. Brownell et al. Cell 84, 843–851; 1996). No histone-modifying enzymatic activity had yet been identified, and no data indicated that transcription machinery might include such activity. The impact of Allis's discovery was immediate and immense, leading to an explosion in papers on HATs. The importance of histone acetylation in transcriptional regulation is now unquestioned.

Allis also had a pivotal role in defining the cause-and-effect relationship between specific modifications and gene expression. His work, more than that of any other, sparked a renaissance in the study of gene regulation through chromatin structure.

Allis settled at the Rockefeller University in New York City in 2003, after appointments at Syracuse University in New York, the University of Rochester and the University of Virginia in Charlottesville. He went on to describe the role of histone modifications beyond acetylation, including a connection between histone phosphorylation and the segregation of chromosomes during cell division. He and his collaborators uncovered a link between histone mutations and chromatin changes associated with malignant cancers. He was quick to recognize the clinical significance of this, and to note that similar mutations might alter global chromatin states in other illnesses. His work will prove essential in unravelling complex aspects of many diseases and providing new treatments.

Allis had an infectious enthusiasm for science, and he influenced the course of discovery well beyond his own laboratory. He welcomed new ideas and shared tools and expertise that fostered major discoveries by others, such as the identification of histone methyltransferase enzymes and the discovery that site-specific histone methylation patterns define chromatin domains as ‘open’ (accessible to gene transcription machinery) and ‘closed’ (relatively inaccessible). For example, histone H3 turned out to perform two opposite functions depending on the methylation states of two lysine residues only a few amino acids apart, which are read by specific protein ligands. This provided crucial evidence for the existence of the histone code (B. D. Strahl and C. D. Allis Nature 403, 41–45; 2000). Allis's paper on this hypothesis has now been cited more than 6,000 times.

Allis was known for his warmth, creativity and humour. In accepting his many honours, he showed huge appreciation for his lab members and the community of colleagues and collaborators, citing them as the inspiring force behind his own success. He cherished his family, crediting the support of his wife Barb with his accomplishments, and proudly sharing pictures of his children and grandchildren.

He celebrated colleagues around the globe by sending them quirky, treasured mementos to honour their findings, among them hats decorated with HAT modifications, or cartoons such as one that invoked iconic cereal box-covers featuring Olympians, tweaked to celebrate the discovery of differential histone methylation patterns specifying distinct gene expression states. We end by saying to him what he often said to others to recognize major achievements: "Good show!" We miss you, Dave.

Nature 614, 409 (2023)

doi: https://doi.org/10.1038/d41586-023-00346-0

The authors declare no competing interests.

Read the paper: SARS-CoV-2 disrupts host epigenetic regulation via histone mimicry

SARS-CoV-2 mimics a host protein to bypass defences

The molecular hallmarks of epigenetic control

The language of covalent histone modifications

Researcher under fire for New Yorker epigenetics article

Powerful microscope captures motor proteins in unprecedented detail

Technology Feature 08 JUN 23

Heritable transcriptional defects from aberrations of nuclear architecture

Article 07 JUN 23

A cytosolic surveillance mechanism activates the mitochondrial UPR

Article 07 JUN 23

Brain-zapping technology helps smokers to quit

Outlook 07 JUN 23

Does shingles vaccination cut dementia risk? Large study hints at a link

News 06 JUN 23

Axonemal structures reveal mechanoregulatory and disease mechanisms

Article 31 MAY 23

A druggable copper-signalling pathway that drives inflammation

Article 26 APR 23

Large-scale mapping and mutagenesis of human transcriptional effector domains

Article 05 APR 23

Basis of the H2AK119 specificity of the Polycomb repressive deubiquitinase

Article 29 MAR 23

All outstanding talents are warmly welcome to join Nanchang University to contribute yours wisdoms, realize your dreams and seek common development!

Nanchang, Jiangxi, China

Nanchang University

Two-year postdoctoral fellowship on carbon burial in marine sediments at Umeå University, Sweden

Umeå, Sweden

Umeå University (KBC)

Join Us and Create a Bright Future Together!

Shanghai, China

East China University of Science and Technology (ECUST)

Southern University of Science and Technology (SUSTech) is a public research university funded by Shenzhen city. Widely regarded as a pioneer and i...

Shenzhen

Southern University of Science and Technology (SUSTech)

Chinese Academy of Sciences, seeks exceptional, creative scientists to join its faculty.

Shanghai, China

The Institute of Neuroscience,Center for Excellence in Brain Science and Intelligence Technology,CAS